3.6.0.2 html 399 565 1 false 124 0 false 9 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.amagpharma.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.amagpharma.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.amagpharma.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.amagpharma.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1003000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://www.amagpharma.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 5 false false R6.htm 1004000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.amagpharma.com/role/ConsolidatedStatementsOfStockholdersEquity CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 1004001 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.amagpharma.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 1005000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.amagpharma.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 2101100 - Disclosure - Description of Business Sheet http://www.amagpharma.com/role/DescriptionOfBusiness Description of Business Notes 9 false false R10.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 2103100 - Disclosure - Business Combinations Sheet http://www.amagpharma.com/role/BusinessCombinations Business Combinations Notes 11 false false R12.htm 2104100 - Disclosure - Investments Sheet http://www.amagpharma.com/role/Investments Investments Notes 12 false false R13.htm 2105100 - Disclosure - Fair Value Measurements Sheet http://www.amagpharma.com/role/FairValueMeasurements Fair Value Measurements Notes 13 false false R14.htm 2106100 - Disclosure - Inventories Sheet http://www.amagpharma.com/role/Inventories Inventories Notes 14 false false R15.htm 2107100 - Disclosure - Property, Plant and Equipment, Net Sheet http://www.amagpharma.com/role/PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net Notes 15 false false R16.htm 2108100 - Disclosure - Goodwill and Intangible Assets, Net Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNet Goodwill and Intangible Assets, Net Notes 16 false false R17.htm 2109100 - Disclosure - Current and Long- Term Liabilities Sheet http://www.amagpharma.com/role/CurrentAndLongTermLiabilities Current and Long- Term Liabilities Notes 17 false false R18.htm 2112100 - Disclosure - Income Taxes Sheet http://www.amagpharma.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2113100 - Disclosure - Accumulated Other Comprehensive Income (Loss) Sheet http://www.amagpharma.com/role/AccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income (Loss) Notes 19 false false R20.htm 2114100 - Disclosure - Equity-Based Compensation Sheet http://www.amagpharma.com/role/EquityBasedCompensation Equity-Based Compensation Notes 20 false false R21.htm 2115100 - Disclosure - Employee Savings Plan Sheet http://www.amagpharma.com/role/EmployeeSavingsPlan Employee Savings Plan Notes 21 false false R22.htm 2116100 - Disclosure - Stockholders' Equity Sheet http://www.amagpharma.com/role/StockholdersEquity Stockholders' Equity Notes 22 false false R23.htm 2117100 - Disclosure - Business Segments Sheet http://www.amagpharma.com/role/BusinessSegments Business Segments Notes 23 false false R24.htm 2118100 - Disclosure - Commitments and Contingencies Sheet http://www.amagpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 24 false false R25.htm 2119100 - Disclosure - Collaboration, License and Other Strategic Agreements Sheet http://www.amagpharma.com/role/CollaborationLicenseAndOtherStrategicAgreements Collaboration, License and Other Strategic Agreements Notes 25 false false R26.htm 2120100 - Disclosure - Debt Sheet http://www.amagpharma.com/role/Debt Debt Notes 26 false false R27.htm 2121100 - Disclosure - Restructuring Sheet http://www.amagpharma.com/role/Restructuring Restructuring Notes 27 false false R28.htm 2122100 - Disclosure - Consolidated Quarterly Financial Data - Unaudited Sheet http://www.amagpharma.com/role/ConsolidatedQuarterlyFinancialDataUnaudited Consolidated Quarterly Financial Data - Unaudited Notes 28 false false R29.htm 2123100 - Disclosure - Valuation And Qualifying Accounts (In Thousands) Sheet http://www.amagpharma.com/role/ValuationAndQualifyingAccountsInThousands Valuation And Qualifying Accounts (In Thousands) Notes 29 false false R30.htm 2124100 - Disclosure - Recently Issued and Proposed Accounting Pronouncements Sheet http://www.amagpharma.com/role/RecentlyIssuedAndProposedAccountingPronouncements Recently Issued and Proposed Accounting Pronouncements Notes 30 false false R31.htm 2125100 - Disclosure - Subsequent Events Sheet http://www.amagpharma.com/role/SubsequentEvents Subsequent Events Notes 31 false false R32.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.amagpharma.com/role/SummaryOfSignificantAccountingPolicies 32 false false R33.htm 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.amagpharma.com/role/SummaryOfSignificantAccountingPolicies 33 false false R34.htm 2303301 - Disclosure - Business Combinations (Tables) Sheet http://www.amagpharma.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://www.amagpharma.com/role/BusinessCombinations 34 false false R35.htm 2304301 - Disclosure - Investments (Tables) Sheet http://www.amagpharma.com/role/InvestmentsTables Investments (Tables) Tables http://www.amagpharma.com/role/Investments 35 false false R36.htm 2305301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.amagpharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.amagpharma.com/role/FairValueMeasurements 36 false false R37.htm 2306301 - Disclosure - Inventories (Tables) Sheet http://www.amagpharma.com/role/InventoriesTables Inventories (Tables) Tables http://www.amagpharma.com/role/Inventories 37 false false R38.htm 2307301 - Disclosure - Property, Plant and Equipment, Net (Tables) Sheet http://www.amagpharma.com/role/PropertyPlantAndEquipmentNetTables Property, Plant and Equipment, Net (Tables) Tables http://www.amagpharma.com/role/PropertyPlantAndEquipmentNet 38 false false R39.htm 2308301 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNet 39 false false R40.htm 2309301 - Disclosure - Current and Long- Term Liabilities (Tables) Sheet http://www.amagpharma.com/role/CurrentAndLongTermLiabilitiesTables Current and Long- Term Liabilities (Tables) Tables http://www.amagpharma.com/role/CurrentAndLongTermLiabilities 40 false false R41.htm 2312301 - Disclosure - Income Taxes (Tables) Sheet http://www.amagpharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.amagpharma.com/role/IncomeTaxes 41 false false R42.htm 2313301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.amagpharma.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) (Tables) Tables http://www.amagpharma.com/role/AccumulatedOtherComprehensiveIncomeLoss 42 false false R43.htm 2314301 - Disclosure - Equity-Based Compensation (Tables) Sheet http://www.amagpharma.com/role/EquityBasedCompensationTables Equity-Based Compensation (Tables) Tables http://www.amagpharma.com/role/EquityBasedCompensation 43 false false R44.htm 2318301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.amagpharma.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.amagpharma.com/role/CommitmentsAndContingencies 44 false false R45.htm 2320301 - Disclosure - Debt (Tables) Sheet http://www.amagpharma.com/role/DebtTables Debt (Tables) Tables http://www.amagpharma.com/role/Debt 45 false false R46.htm 2321301 - Disclosure - Restructuring (Tables) Sheet http://www.amagpharma.com/role/RestructuringTables Restructuring (Tables) Tables http://www.amagpharma.com/role/Restructuring 46 false false R47.htm 2322301 - Disclosure - Consolidated Quarterly Financial Data - Unaudited (Tables) Sheet http://www.amagpharma.com/role/ConsolidatedQuarterlyFinancialDataUnauditedTables Consolidated Quarterly Financial Data - Unaudited (Tables) Tables http://www.amagpharma.com/role/ConsolidatedQuarterlyFinancialDataUnaudited 47 false false R48.htm 2323301 - Disclosure - Valuation And Qualifying Accounts (In Thousands) (Tables) Sheet http://www.amagpharma.com/role/ValuationAndQualifyingAccountsInThousandsTables Valuation And Qualifying Accounts (In Thousands) (Tables) Tables http://www.amagpharma.com/role/ValuationAndQualifyingAccountsInThousands 48 false false R49.htm 2402403 - Disclosure - Summary of Significant Accounting Policies - Inventory (Details) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesInventoryDetails Summary of Significant Accounting Policies - Inventory (Details) Details 49 false false R50.htm 2402404 - Disclosure - Summary of Significant Accounting Policies - Restricted Cash (Details) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesRestrictedCashDetails Summary of Significant Accounting Policies - Restricted Cash (Details) Details 50 false false R51.htm 2402405 - Disclosure - Summary of Significant Accounting Policies - Customers Who Represent 10% or More Of Total Revenues Or Accounts Receivable Balances (Details) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesCustomersWhoRepresent10OrMoreOfTotalRevenuesOrAccountsReceivableBalancesDetails Summary of Significant Accounting Policies - Customers Who Represent 10% or More Of Total Revenues Or Accounts Receivable Balances (Details) Details 51 false false R52.htm 2402406 - Disclosure - Summary of Significant Accounting Policies - Property, Plant and Equipment, Net (Details) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentNetDetails Summary of Significant Accounting Policies - Property, Plant and Equipment, Net (Details) Details 52 false false R53.htm 2402407 - Disclosure - Summary of Significant Accounting Policies - Product Revenue (Details) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesProductRevenueDetails Summary of Significant Accounting Policies - Product Revenue (Details) Details 53 false false R54.htm 2402408 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesAdvertisingCostsDetails Summary of Significant Accounting Policies - Advertising Costs (Details) Details 54 false false R55.htm 2402409 - Disclosure - Summary of Significant Accounting Policies - Basic and Diluted Net Income (Loss) per Share (Details) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerShareDetails Summary of Significant Accounting Policies - Basic and Diluted Net Income (Loss) per Share (Details) Details 55 false false R56.htm 2402410 - Disclosure - Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities excluded from Computation of Earnings per Share (Details) Sheet http://www.amagpharma.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAntiDilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities excluded from Computation of Earnings per Share (Details) Details 56 false false R57.htm 2403402 - Disclosure - Business Combinations - Narrative - CBR Acquisition (Details) Sheet http://www.amagpharma.com/role/BusinessCombinationsNarrativeCbrAcquisitionDetails Business Combinations - Narrative - CBR Acquisition (Details) Details 57 false false R58.htm 2403403 - Disclosure - Business Combinations - Total Acquisition Date Fair Value (Details) Sheet http://www.amagpharma.com/role/BusinessCombinationsTotalAcquisitionDateFairValueDetails Business Combinations - Total Acquisition Date Fair Value (Details) Details 58 false false R59.htm 2403404 - Disclosure - Business Combinations - Narrative - Lumara Health Acquisition (Details) Sheet http://www.amagpharma.com/role/BusinessCombinationsNarrativeLumaraHealthAcquisitionDetails Business Combinations - Narrative - Lumara Health Acquisition (Details) Details 59 false false R60.htm 2403405 - Disclosure - Business Combinations - Narrative - Unaudited Pro Forma Supplemental Information (Details) Sheet http://www.amagpharma.com/role/BusinessCombinationsNarrativeUnauditedProFormaSupplementalInformationDetails Business Combinations - Narrative - Unaudited Pro Forma Supplemental Information (Details) Details 60 false false R61.htm 2403406 - Disclosure - Business Combinations - Summary of Unaudited Pro Forma Results (Details) Sheet http://www.amagpharma.com/role/BusinessCombinationsSummaryOfUnauditedProFormaResultsDetails Business Combinations - Summary of Unaudited Pro Forma Results (Details) Details 61 false false R62.htm 2403407 - Disclosure - Business Combinations - Goodwill (Details) Sheet http://www.amagpharma.com/role/BusinessCombinationsGoodwillDetails Business Combinations - Goodwill (Details) Details 62 false false R63.htm 2404402 - Disclosure - Investments (Details) Sheet http://www.amagpharma.com/role/InvestmentsDetails Investments (Details) Details http://www.amagpharma.com/role/InvestmentsTables 63 false false R64.htm 2405402 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.amagpharma.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 64 false false R65.htm 2405403 - Disclosure - Fair Value Measurements - Contingent Consideration (Details) Sheet http://www.amagpharma.com/role/FairValueMeasurementsContingentConsiderationDetails Fair Value Measurements - Contingent Consideration (Details) Details 65 false false R66.htm 2405404 - Disclosure - Fair Value Measurements - Debt (Details) Sheet http://www.amagpharma.com/role/FairValueMeasurementsDebtDetails Fair Value Measurements - Debt (Details) Details 66 false false R67.htm 2406402 - Disclosure - Inventories (Details) Sheet http://www.amagpharma.com/role/InventoriesDetails Inventories (Details) Details http://www.amagpharma.com/role/InventoriesTables 67 false false R68.htm 2407402 - Disclosure - Property, Plant and Equipment, Net (Details) Sheet http://www.amagpharma.com/role/PropertyPlantAndEquipmentNetDetails Property, Plant and Equipment, Net (Details) Details http://www.amagpharma.com/role/PropertyPlantAndEquipmentNetTables 68 false false R69.htm 2408402 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetScheduleOfGoodwillDetails Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) Details 69 false false R70.htm 2408403 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill - Narrative (Details) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetGoodwillNarrativeDetails Goodwill and Intangible Assets, Net - Goodwill - Narrative (Details) Details 70 false false R71.htm 2408404 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetScheduleOfIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) Details 71 false false R72.htm 2408405 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets - Narrative (Details) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetIntangibleAssetsNarrativeDetails Goodwill and Intangible Assets, Net - Intangible Assets - Narrative (Details) Details 72 false false R73.htm 2408406 - Disclosure - Goodwill and Intangible Assets, Net - Amortization Expense (Details) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetAmortizationExpenseDetails Goodwill and Intangible Assets, Net - Amortization Expense (Details) Details 73 false false R74.htm 2409402 - Disclosure - Current and Long- Term Liabilities (Details) Sheet http://www.amagpharma.com/role/CurrentAndLongTermLiabilitiesDetails Current and Long- Term Liabilities (Details) Details http://www.amagpharma.com/role/CurrentAndLongTermLiabilitiesTables 74 false false R75.htm 2412402 - Disclosure - Income Taxes - Schedule of Income Tax Expense (Benefit) (Details) Sheet http://www.amagpharma.com/role/IncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetails Income Taxes - Schedule of Income Tax Expense (Benefit) (Details) Details 75 false false R76.htm 2412403 - Disclosure - Income Taxes - Income Tax Reconciliation (Details) Sheet http://www.amagpharma.com/role/IncomeTaxesIncomeTaxReconciliationDetails Income Taxes - Income Tax Reconciliation (Details) Details 76 false false R77.htm 2412404 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.amagpharma.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 77 false false R78.htm 2412405 - Disclosure - Income Taxes - Deferred Tax Components (Details) Sheet http://www.amagpharma.com/role/IncomeTaxesDeferredTaxComponentsDetails Income Taxes - Deferred Tax Components (Details) Details 78 false false R79.htm 2412406 - Disclosure - Income Taxes - Carryforward (Details) Sheet http://www.amagpharma.com/role/IncomeTaxesCarryforwardDetails Income Taxes - Carryforward (Details) Details 79 false false R80.htm 2412407 - Disclosure - Income Taxes - Reconciliation of Uncertain Tax Positions (Details) Sheet http://www.amagpharma.com/role/IncomeTaxesReconciliationOfUncertainTaxPositionsDetails Income Taxes - Reconciliation of Uncertain Tax Positions (Details) Details 80 false false R81.htm 2413402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.amagpharma.com/role/AccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) (Details) Details http://www.amagpharma.com/role/AccumulatedOtherComprehensiveIncomeLossTables 81 false false R82.htm 2414402 - Disclosure - Equity-Based Compensation - Narrative (Details) Sheet http://www.amagpharma.com/role/EquityBasedCompensationNarrativeDetails Equity-Based Compensation - Narrative (Details) Details 82 false false R83.htm 2414403 - Disclosure - Equity-Based Compensation - Activity Related to Plans (Details) Sheet http://www.amagpharma.com/role/EquityBasedCompensationActivityRelatedToPlansDetails Equity-Based Compensation - Activity Related to Plans (Details) Details 83 false false R84.htm 2414404 - Disclosure - Equity-Based Compensation - Equity-Based Compensation Expense (Details) Sheet http://www.amagpharma.com/role/EquityBasedCompensationEquityBasedCompensationExpenseDetails Equity-Based Compensation - Equity-Based Compensation Expense (Details) Details 84 false false R85.htm 2414405 - Disclosure - Equity-Based Compensation - Weighted-Average Fair Value Assumptions, Stock Option Activity (Details) Sheet http://www.amagpharma.com/role/EquityBasedCompensationWeightedAverageFairValueAssumptionsStockOptionActivityDetails Equity-Based Compensation - Weighted-Average Fair Value Assumptions, Stock Option Activity (Details) Details 85 false false R86.htm 2414406 - Disclosure - Equity-Based Compensation - Schedule of Stock-based Compensation (Details) Sheet http://www.amagpharma.com/role/EquityBasedCompensationScheduleOfStockBasedCompensationDetails Equity-Based Compensation - Schedule of Stock-based Compensation (Details) Details 86 false false R87.htm 2414407 - Disclosure - Equity-Based Compensation - Schedule of RSUs Granted (Details) Sheet http://www.amagpharma.com/role/EquityBasedCompensationScheduleOfRsusGrantedDetails Equity-Based Compensation - Schedule of RSUs Granted (Details) Details 87 false false R88.htm 2415401 - Disclosure - Employee Savings Plan (Details) Sheet http://www.amagpharma.com/role/EmployeeSavingsPlanDetails Employee Savings Plan (Details) Details http://www.amagpharma.com/role/EmployeeSavingsPlan 88 false false R89.htm 2416401 - Disclosure - Stockholders' Equity (Details) Sheet http://www.amagpharma.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.amagpharma.com/role/StockholdersEquity 89 false false R90.htm 2417401 - Disclosure - Business Segments (Details) Sheet http://www.amagpharma.com/role/BusinessSegmentsDetails Business Segments (Details) Details http://www.amagpharma.com/role/BusinessSegments 90 false false R91.htm 2418402 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.amagpharma.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 91 false false R92.htm 2418403 - Disclosure - Commitments and Contingencies - Operating Leases, Fiscal Year Maturity Schedule (Details) Sheet http://www.amagpharma.com/role/CommitmentsAndContingenciesOperatingLeasesFiscalYearMaturityScheduleDetails Commitments and Contingencies - Operating Leases, Fiscal Year Maturity Schedule (Details) Details 92 false false R93.htm 2419401 - Disclosure - Collaboration, License and Other Strategic Agreements (Details) Sheet http://www.amagpharma.com/role/CollaborationLicenseAndOtherStrategicAgreementsDetails Collaboration, License and Other Strategic Agreements (Details) Details http://www.amagpharma.com/role/CollaborationLicenseAndOtherStrategicAgreements 93 false false R94.htm 2420402 - Disclosure - Debt - Schedule of Outstanding Debt Obligations (Details) Sheet http://www.amagpharma.com/role/DebtScheduleOfOutstandingDebtObligationsDetails Debt - Schedule of Outstanding Debt Obligations (Details) Details 94 false false R95.htm 2420403 - Disclosure - Debt - 2023 Senior Notes (Details) Notes http://www.amagpharma.com/role/Debt2023SeniorNotesDetails Debt - 2023 Senior Notes (Details) Details 95 false false R96.htm 2420404 - Disclosure - Debt - 2015 Term Loan Facility (Details) Sheet http://www.amagpharma.com/role/Debt2015TermLoanFacilityDetails Debt - 2015 Term Loan Facility (Details) Details 96 false false R97.htm 2420405 - Disclosure - Debt - 2.5% Convertible Notes (Details) Notes http://www.amagpharma.com/role/Debt25ConvertibleNotesDetails Debt - 2.5% Convertible Notes (Details) Details 97 false false R98.htm 2420406 - Disclosure - Debt - Outstanding Convertible Note Balances (Details) Sheet http://www.amagpharma.com/role/DebtOutstandingConvertibleNoteBalancesDetails Debt - Outstanding Convertible Note Balances (Details) Details 98 false false R99.htm 2420407 - Disclosure - Debt - Schedule of Total Interest Expense Recognized Related to the Convertible Notes (Details) Notes http://www.amagpharma.com/role/DebtScheduleOfTotalInterestExpenseRecognizedRelatedToConvertibleNotesDetails Debt - Schedule of Total Interest Expense Recognized Related to the Convertible Notes (Details) Details 99 false false R100.htm 2420408 - Disclosure - Debt - Convertible Bond Hedge, Warrant Transactions (Details) Sheet http://www.amagpharma.com/role/DebtConvertibleBondHedgeWarrantTransactionsDetails Debt - Convertible Bond Hedge, Warrant Transactions (Details) Details 100 false false R101.htm 2420409 - Disclosure - Debt - Future Payments (Details) Sheet http://www.amagpharma.com/role/DebtFuturePaymentsDetails Debt - Future Payments (Details) Details 101 false false R102.htm 2421402 - Disclosure - Restructuring (Details) Sheet http://www.amagpharma.com/role/RestructuringDetails Restructuring (Details) Details http://www.amagpharma.com/role/RestructuringTables 102 false false R103.htm 2422402 - Disclosure - Consolidated Quarterly Financial Data - Unaudited (Details) Sheet http://www.amagpharma.com/role/ConsolidatedQuarterlyFinancialDataUnauditedDetails Consolidated Quarterly Financial Data - Unaudited (Details) Details http://www.amagpharma.com/role/ConsolidatedQuarterlyFinancialDataUnauditedTables 103 false false R104.htm 2423402 - Disclosure - Valuation And Qualifying Accounts (In Thousands) (Details) Sheet http://www.amagpharma.com/role/ValuationAndQualifyingAccountsInThousandsDetails Valuation And Qualifying Accounts (In Thousands) (Details) Details http://www.amagpharma.com/role/ValuationAndQualifyingAccountsInThousandsTables 104 false false R105.htm 2424401 - Disclosure - Recently Issued and Proposed Accounting Pronouncements (Details) Sheet http://www.amagpharma.com/role/RecentlyIssuedAndProposedAccountingPronouncementsDetails Recently Issued and Proposed Accounting Pronouncements (Details) Details http://www.amagpharma.com/role/RecentlyIssuedAndProposedAccountingPronouncements 105 false false R106.htm 2425401 - Disclosure - Subsequent Events (Details) Sheet http://www.amagpharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.amagpharma.com/role/SubsequentEvents 106 false false All Reports Book All Reports amag-20161231.xml amag-20161231.xsd amag-20161231_cal.xml amag-20161231_def.xml amag-20161231_lab.xml amag-20161231_pre.xml true true